Hasan Kahraman1, Mustafa Haki Sucaklı2, Nurhan Atilla1, Hüseyin Arpağ1, Fulsen Bozkuş1, Nurhan Köksal3. 1. Department of Chest Disease, Kahramanmaraş Sütçü İmam University School of Medicine, Kahramanmaraş, Turkey. 2. Department of Family Medicine, Kahramanmaraş Sütçü İmam University School of Medicine, Kahramanmaraş, Turkey. 3. Department of Chest Disease, Ondokuz Mayıs University School of Medicine, Samsun, Turkey.
Abstract
OBJECTIVES: The aim of this study was to evaluate whether smokeless tobacco (Maras powder) use increased among smokers working at smoke-free workplaces or not. MATERIAL AND METHODS: In Kahramanmaraş city, 242 male workers who were current or former smokers, working at strictly smoke-free workplaces were included in this study. A total of 21 questions, including the Fagerstrom Test for Nicotine Dependence, were asked. RESULTS: All the participants were male with a mean age of 29.33±6.66 years, and the age range was 17-55 years. Current smokers were 90 (37.2%) and former smokers were 152 (62.8%). Former smokers were asked the reason why they quit smoking; the predominant reasons were the health hazards of smoking and the financial burden of cigarettes. The quitting rate was significantly higher among married participants (p=0.023). Maras powder users were 184 (76%), users who never smoked were 54 (22.3%), and former users were 4 (1.7%). We asked the Maras powder users if they had been using it before the smoking bans, and 96 workers (51.1%) answered "no." The question "Did the use of Maras powder increase with smoking bans"? was asked, and 118 workers (62.8%) answered "yes." The level of education among Maras powder users was significantly lower than non-users (p=0.001). CONCLUSION: Working in smoke-free workplaces is associated with increased rates of quitting smoking and also with increased use of Maras powder, a local form of oral smokeless tobacco.
OBJECTIVES: The aim of this study was to evaluate whether smokeless tobacco (Maras powder) use increased among smokers working at smoke-free workplaces or not. MATERIAL AND METHODS: In Kahramanmaraş city, 242 male workers who were current or former smokers, working at strictly smoke-free workplaces were included in this study. A total of 21 questions, including the Fagerstrom Test for Nicotine Dependence, were asked. RESULTS: All the participants were male with a mean age of 29.33±6.66 years, and the age range was 17-55 years. Current smokers were 90 (37.2%) and former smokers were 152 (62.8%). Former smokers were asked the reason why they quit smoking; the predominant reasons were the health hazards of smoking and the financial burden of cigarettes. The quitting rate was significantly higher among married participants (p=0.023). Maras powder users were 184 (76%), users who never smoked were 54 (22.3%), and former users were 4 (1.7%). We asked the Maras powder users if they had been using it before the smoking bans, and 96 workers (51.1%) answered "no." The question "Did the use of Maras powder increase with smoking bans"? was asked, and 118 workers (62.8%) answered "yes." The level of education among Maras powder users was significantly lower than non-users (p=0.001). CONCLUSION: Working in smoke-free workplaces is associated with increased rates of quitting smoking and also with increased use of Maras powder, a local form of oral smokeless tobacco.
Authors: Mariann R Piano; Neal L Benowitz; Garret A Fitzgerald; Susan Corbridge; Janie Heath; Ellen Hahn; Terry F Pechacek; George Howard Journal: Circulation Date: 2010-09-13 Impact factor: 29.690
Authors: Gary A Giovino; Sara A Mirza; Jonathan M Samet; Prakash C Gupta; Martin J Jarvis; Neeraj Bhala; Richard Peto; Witold Zatonski; Jason Hsia; Jeremy Morton; Krishna M Palipudi; Samira Asma Journal: Lancet Date: 2012-08-18 Impact factor: 79.321
Authors: Ahmet Akcay; M Naci Aydin; Gurkan Acar; Bulent Mese; Mustafa Çetin; Mehmet Akgungor; Eren Cabioglu; Orhan Bozoglan; Idris Ardic; Musa Çakici Journal: Cardiovasc J Afr Date: 2015 May-Jun Impact factor: 1.167
Authors: Luca Enrico Ruscitti; Fulvio Castellani; Giuseppe La Torre; Maria De Giusti; Fabio Dominici; Pasquale Valente Journal: Med Lav Date: 2021-02-23 Impact factor: 1.275